Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quantitative Trait Loci | 5 | 2018 | 665 | 1.090 |
Why?
|
| Models, Statistical | 4 | 2019 | 602 | 0.900 |
Why?
|
| Algorithms | 6 | 2019 | 2001 | 0.890 |
Why?
|
| Proteomics | 2 | 2019 | 279 | 0.860 |
Why?
|
| Genome-Wide Association Study | 8 | 2018 | 1858 | 0.690 |
Why?
|
| Biostatistics | 1 | 2019 | 21 | 0.600 |
Why?
|
| Gene-Environment Interaction | 2 | 2018 | 125 | 0.590 |
Why?
|
| Models, Genetic | 5 | 2018 | 1006 | 0.550 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 2020 | 0.530 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 1566 | 0.520 |
Why?
|
| Genotype | 3 | 2016 | 1891 | 0.450 |
Why?
|
| Gene Regulatory Networks | 3 | 2017 | 340 | 0.400 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2018 | 2570 | 0.360 |
Why?
|
| Genomics | 2 | 2018 | 902 | 0.360 |
Why?
|
| Computer Simulation | 6 | 2018 | 1147 | 0.350 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 310 | 0.340 |
Why?
|
| Genetic Variation | 3 | 2018 | 1452 | 0.330 |
Why?
|
| Transcriptome | 1 | 2016 | 822 | 0.310 |
Why?
|
| Genetics, Population | 1 | 2013 | 450 | 0.300 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 571 | 0.280 |
Why?
|
| Lod Score | 1 | 2006 | 152 | 0.240 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2006 | 135 | 0.220 |
Why?
|
| DNA Methylation | 2 | 2019 | 734 | 0.200 |
Why?
|
| Genome | 1 | 2006 | 417 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 2569 | 0.190 |
Why?
|
| Principal Component Analysis | 2 | 2013 | 170 | 0.170 |
Why?
|
| Humans | 13 | 2019 | 98223 | 0.140 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 203 | 0.140 |
Why?
|
| Penetrance | 1 | 2018 | 51 | 0.130 |
Why?
|
| Phenotype | 2 | 2016 | 2653 | 0.130 |
Why?
|
| Tissue Distribution | 1 | 2017 | 290 | 0.130 |
Why?
|
| Biometry | 2 | 2015 | 70 | 0.130 |
Why?
|
| Breast Density | 1 | 2017 | 44 | 0.130 |
Why?
|
| Age of Onset | 1 | 2018 | 368 | 0.120 |
Why?
|
| Age Factors | 2 | 2018 | 1972 | 0.120 |
Why?
|
| Databases, Genetic | 1 | 2017 | 289 | 0.120 |
Why?
|
| Breast | 1 | 2017 | 315 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2014 | 37 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 311 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 188 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2014 | 258 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 3279 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 2014 | 148 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2016 | 970 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2017 | 572 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 828 | 0.090 |
Why?
|
| Genome, Human | 2 | 2018 | 833 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 554 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1009 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2013 | 716 | 0.080 |
Why?
|
| Risk Factors | 2 | 2018 | 6269 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2789 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2010 | 577 | 0.070 |
Why?
|
| Pharmacogenetics | 1 | 2012 | 473 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2013 | 2002 | 0.070 |
Why?
|
| Yeasts | 1 | 2007 | 50 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2006 | 214 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 584 | 0.060 |
Why?
|
| Bangladesh | 2 | 2018 | 361 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2006 | 236 | 0.050 |
Why?
|
| Female | 5 | 2019 | 51685 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 1063 | 0.050 |
Why?
|
| Proteogenomics | 1 | 2019 | 9 | 0.040 |
Why?
|
| Ultrasonography, Mammary | 1 | 2017 | 86 | 0.030 |
Why?
|
| Vitamin E | 1 | 2014 | 34 | 0.030 |
Why?
|
| Asia | 1 | 2014 | 109 | 0.030 |
Why?
|
| Selenium | 1 | 2014 | 46 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2014 | 93 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1321 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1395 | 0.020 |
Why?
|
| Mammography | 1 | 2017 | 504 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 1142 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1114 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2598 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 638 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 770 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 29548 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3611 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 7556 | 0.010 |
Why?
|
| Male | 2 | 2018 | 47195 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 29494 | 0.010 |
Why?
|